Evidence-Based in Clinical Behavioral Infectivology

Size: px
Start display at page:

Download "Evidence-Based in Clinical Behavioral Infectivology"

Transcription

1 LEZIONI DI PSICOINFETTIVOLOGIA Chieti 9-10 Marzo 2018 Evidence-Based in Clinical Behavioral Infectivology Francesco Vadini 1

2 MALATTIA INFETTIVA PER MALATTIA INFETTIVA SI INTENDE UNA PATOLOGIA DOVUTA AL CONTAGIO DELL ORGANISMO UMANO DA PARTE DI MICRORGANISMI: BATTERI VIRUS PARASSITI ECC. 2

3 PSICOINFETTIVOLOGIA Integrazione delle metodologie di intervento psicologico nelle malattie infettive 3

4 AMBITI DI INTERVENTO PERINATAL PSYCHOINFECTIVOLOGY PEDIATRIC PSYCHOINFECTIVOLOGY CHRONIC INFECTIOUS DISEASE PSYCHOINFECTIVOLOGY COUPLE RELATIONSHIP PSYCHOINFECTIVOLOGY 4

5 CHRONIC INFECTIOUS DISEASE PSYCHOINFECTIVOLOGY INFEZIONE CRONICA DA HIV 5

6 6

7 7

8 Cumulative survival curve for HIV-infected persons and the general population Based on Lohse N, et al. Ann Intern Med 2007;146:

9 Prevalence of comorbidities increases with age and HIV % Number of Comorbidities per Patient HIV Negative HIV Positive Mean Number of Age-Associated Noncommunicable Comorbidities Number of Participants Schouten J, et al. International AIDS Conference Abstract THAB

10 Interplay of age with morbidity HIV Infection ARV Regimen Aging Risk of comorbidities increases as individuals get older HIV does not cause these illnesses However, HIV and/or ART may increase the risk 10

11 DEPRESSIONE E HIV 11

12 Risk factors for depression Number of years living with HIV Avoidance vs. active coping style Excessive rumination about health-related problems Past history of depression Other psychiatric disorder substance use disorders Personality disorders Low social support Low education Primeau et al Carvalhal et al

13 Clinical relevance of depression for patients with HIV Patients with HIV diagnosed with depression can have Declining CD4+ counts Higher viral loads Slower virological response Carrico AW, et al Horberg MA, et al Pence BW, et al

14 Patients with HIV and depression have lower treatment adherence Depression is negatively correlated with treatment adherence in patients with HIV Adherence decreases as the severity of depression increases Patients are more likely to discontinue treatment Cognitive symptoms of depression may affect adherence Lower treatment adherence in patients with HIV and depression leads to an increased viral load Wagner GJ, et al Carrico AW, et al

15 Disturbi psichiatrici e aderenza alle terapie antiretrovirali (HAART) Disorder Odds Ratio* P Value Generalized anxiety disorder 2.4 ( ).02 Panic disorder 2.0 ( ) <.001 Any psychiatric disorder 1.9 ( ) <.001 Depression 1.7 ( ).001 Multiple disorders (OR per disorder) 1.4 ( ) <.001 Dysthymia 1.3 ( ).17 *Adjusted for sex, race, age, education, employment, insurance, CD4+ cell count nadir, HIV status, ART, having a case manager. Tucker JS, et al. Substance use and mental health correlates of non adherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am J Med. 2003;114:

16 Adherence in patients with HIV and depression Reluctance to prescribe HAART to patients with depression because of concerns about adherence Poor outcomes can exacerbate the symptoms of depression Poorer outcomes in patients with HIV and depression HAART, highly active antiretoviral therapy. Hartzell et al. J Antimicrob Chemother 2008;62:

17 Depressione e aumento di mortalità nelle persone sieropositive Study assessed association of depressive symptoms with HIV-related mortality and decline in CD4+ cell counts in HERS cohort (N = 765) 1.0 HIV-Related Mortality Depression (CES-D) defined as limited, intermittent, or chronic Multivariate analysis: increased RR of mortality in women with chronic depressive symptoms (2.0; 95% CI: ) vs those with limited or no symptoms Mortality in patients with CD4+ < 200 Chronic depression: 54%( RR: 4.3; 95% CI: ) vs limited depression Intermittent depression: 48% (RR: 3.5; 95% CI: ) vs limited depression Limited depression: 21% Cumulative Survival Limited depression Intermittent depression Chronic depression Total Time in Study (Yrs) Ickovics JR, et al. JAMA. 2001;285:

18 Screening for depression Ramasubbu R. et al

Differential diagnosis between depression and neurocognitive impairment in HIV-infected persons

Differential diagnosis between depression and neurocognitive impairment in HIV-infected persons Differential diagnosis between depression and neurocognitive impairment in HIV-infected persons Dr. Adriana Carvalhal, MD, MSc, PhD University of Toronto - Canada Disclosure Research: Canadian Institute

More information

Deborah Kacanek, Konstantia Angelidou, Paige L. Williams, Miriam Chernoff, Kenneth Gadow, Sharon Nachman, The IMPAACT P1055 Study Team

Deborah Kacanek, Konstantia Angelidou, Paige L. Williams, Miriam Chernoff, Kenneth Gadow, Sharon Nachman, The IMPAACT P1055 Study Team Psychiatric disorder symptoms are associated with longitudinal changes in antiretroviral (ARV) non-adherence in perinatally HIV-infected youth in the US: Results from IMPAACT P1055 Deborah Kacanek, Konstantia

More information

Psychiatric Comorbidity in Depressed HIV Individuals: Common and Clinically Consequential

Psychiatric Comorbidity in Depressed HIV Individuals: Common and Clinically Consequential Psychiatric Comorbidity in Depressed HIV Individuals: Common and Clinically Consequential Bradley N. Gaynes, MD, MPH Professor of Psychiatry Associate Chair of Research Training and Education University

More information

New England healthcare providers perceptions, knowledge and practices regarding the use of antiretrovirals for prevention

New England healthcare providers perceptions, knowledge and practices regarding the use of antiretrovirals for prevention New England healthcare providers perceptions, knowledge and practices regarding the use of antiretrovirals for prevention Douglas Krakower, Catherine Oldenburg, Jennifer Mitty, Ira Wilson, Ann Kurth, Kevin

More information

Effect of HAART on growth parameters and absolute CD4 count among HIV-infected children in a rural community of central Nigeria

Effect of HAART on growth parameters and absolute CD4 count among HIV-infected children in a rural community of central Nigeria Niger J Paed 2014; 41 (1): 1-6 Ebonyi AO Oguche S Dablets E Sumi B Yakubu E Sagay AS ORIGINAL Effect of HAART on growth parameters and absolute CD4 count among HIV-infected children in a rural community

More information

Prevalence of Comorbidities among HIV-positive patients in Taiwan

Prevalence of Comorbidities among HIV-positive patients in Taiwan Prevalence of Comorbidities among HIV-positive patients in Taiwan Chien-Ching Hung, MD, PhD Department of Internal Medicine National Taiwan University Hospital, Taipei, Taiwan % of participants Comorbidity

More information

Report Back from CROI 2010

Report Back from CROI 2010 Report Back from CROI 2010 Conference on Retroviruses and Opportunistic Infections Edwin Charlebois, MPH PhD Associate Professor of Medicine Department of Medicine University of California, San Francisco

More information

HIV TREATMENT ADHERENCE AND SUPPORT. Leonard Anang Sowah, MBChB, MPH, FACP Asst. Professor of Medicine University of Maryland Medical School

HIV TREATMENT ADHERENCE AND SUPPORT. Leonard Anang Sowah, MBChB, MPH, FACP Asst. Professor of Medicine University of Maryland Medical School HIV TREATMENT ADHERENCE AND SUPPORT Leonard Anang Sowah, MBChB, MPH, FACP Asst. Professor of Medicine University of Maryland Medical School The virus Virus uses host cell machinery to produce viral proteins

More information

The availability and cost are obstacles to using pvl in monitoring HIV treatment outcomes in resource-constrained settings

The availability and cost are obstacles to using pvl in monitoring HIV treatment outcomes in resource-constrained settings Impact of the frequency of plasma viral load monitoring on treatment outcome among perinatally HIVinfected Asian children stable on first-line NNRTI-based cart T Sudjaritruk, DC Boettiger, NV Lam, KAM

More information

Clinical Case. Prof.ssa Cristina Mussini

Clinical Case. Prof.ssa Cristina Mussini Clinical Case Prof.ssa Cristina Mussini Clinical history Male, born in Ivory Coast in 1968. HIV positive since dal 1998 Risk factor: heterosexual contacts He started antiretroviral therapy in 2001 with

More information

Factors Associated with Limitations in Daily Activity Among Older HIV+ Adults

Factors Associated with Limitations in Daily Activity Among Older HIV+ Adults Factors Associated with Limitations in Daily Activity Among Older HIV+ Adults KM Erlandson, K Wu, R Kalayjian, S Koletar, B Taiwo, FJ Palella Jr, K Tassiopoulos and the A5322 Team Background Growing burden

More information

TB e HIV nelle coorti

TB e HIV nelle coorti TB e HIV nelle coorti Antonella d Arminio Monforte Clinica di Malattie Infettive Dipartimento di Scienze della Salute Università degli Studi di Milano Presidio Ospedalero San Paolo, ASST Santi Paolo e

More information

AETC Needs Assessment Question Bank

AETC Needs Assessment Question Bank AETC Needs Assessment Question Bank ABOUT YOUR AGENCY/CLINIC What are the general characteristics of your patient/client population? Race, ethnicity, gender, age, socioeconomic status, cultural identities,

More information

IMPROVING HIV HEALTH OUTCOMES FROM A PERSON-CENTERED APPROACH

IMPROVING HIV HEALTH OUTCOMES FROM A PERSON-CENTERED APPROACH IMPROVING HIV HEALTH OUTCOMES FROM A PERSON-CENTERED APPROACH T R A N S F O R M I N G C A R E C O N F E R E N C E, C O LU M B U S, O H O C T O B E R 1 9, 2 0 1 7 Kelly Wesp, PhD Bonney Harnish, PhD, RN,

More information

Apurba Chakraborty MBBS, MPH Dima M. Qato PharmD, MPH, PhD Professor Mark S. Dworkin MD, MPHTM The University of Illinois at Chicago

Apurba Chakraborty MBBS, MPH Dima M. Qato PharmD, MPH, PhD Professor Mark S. Dworkin MD, MPHTM The University of Illinois at Chicago Less is More: The Impact of Lower Pill Burden on Adherence to Antiretroviral Therapy among Treatment-Naive Patients with HIV Infection in the United States Apurba Chakraborty MBBS, MPH Dima M. Qato PharmD,

More information

HIV-1 Dual Infection and Neurocognitive Impairment

HIV-1 Dual Infection and Neurocognitive Impairment HIV-1 Dual Infection and Neurocognitive Impairment Gabriel Wagner, MD Assistant Professor of Medicine Infectious Diseases & Global Public Health UC San Diego HIV-Associated End Organ Damage Antiretroviral

More information

HIV-HBV coinfection in HIV population horizontally infected in early childhood between

HIV-HBV coinfection in HIV population horizontally infected in early childhood between UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA FACULTY OF MEDICINE HIV-HBV coinfection in HIV population horizontally infected in early childhood between 1987-1990 Supervising professor: Prof. Cupşa Augustin

More information

Supervised Treatment Interruption (STI) in an Urban HIV Clinical Practice: A Prospective Analysis.

Supervised Treatment Interruption (STI) in an Urban HIV Clinical Practice: A Prospective Analysis. Supervised Treatment Interruption (STI) in an Urban HIV Clinical Practice: A Prospective Analysis. J.L. YOZVIAK 1, P. KOUVATSOS 2, R.E. DOERFLER 3, W.C. WOODWARD 3 1 Philadelphia College of Osteopathic

More information

DNA Genotyping in HIV Infection

DNA Genotyping in HIV Infection Frontier AIDS Education and Training Center DNA Genotyping in HIV Infection Steven C. Johnson M.D. Director, University of Colorado HIV/AIDS Clinical Program; Professor of Medicine, Division of Infectious

More information

HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016

HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016 HIV Drug Resistance South Africa, How to address the increasing need? 14 Apr. 2016 1 Thus the HIV DR needs to focus on prevention and then diagnostic capacity to 1 st provide VL monitoring for early &

More information

Cascade of medical care to HIV-infected patients in Europe. Cristina Mussini

Cascade of medical care to HIV-infected patients in Europe. Cristina Mussini Cascade of medical care to HIV-infected patients in Europe Cristina Mussini UNAIDS: New HIV treatment target 90% of people tested 90% of people diagnosed with HIV on treatment 90% of people on treatment

More information

Mortalité et Morbidité à l ère des traitements antirétroviraux dans les Pays du Nord

Mortalité et Morbidité à l ère des traitements antirétroviraux dans les Pays du Nord Mortalité et Morbidité à l ère des traitements antirétroviraux dans les Pays du Nord Laurence WEISS Hôpital Européen Georges Pompidou, Université Paris-Descartes Paris, France Deaths per 100 Person-Years

More information

HIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI

HIV Infection in Pregnancy. Francis J. Ndowa WHO RHR/STI HIV Infection in Pregnancy Francis J. Ndowa WHO RHR/STI FJN_STI_2005 Department of reproductive health and research Département santé et recherche génésiques Session outline Effect of pregnancy on HIV

More information

A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia

A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia ORIGINAL PAPER A Descriptive Study of Outcomes of Interventions to Prevent Mother to Child Transmission of HIV in Lusaka, Zambia Chibesa Shichitamba W, National Malaria Control Centre, Lusaka-Zambia ABSTRACT

More information

Low-Level Viremia in HIV

Low-Level Viremia in HIV Mountain West AIDS Education and Training Center Low-Level Viremia in HIV Brian R. Wood, MD Medical Director, Mountain West AETC ECHO Telehealth Program Assistant Professor of Medicine, University of Washington

More information

The Role of Violence in Stimulant Use among Homeless and Unstably Housed Adult Women Living in a U.S. Urban Setting

The Role of Violence in Stimulant Use among Homeless and Unstably Housed Adult Women Living in a U.S. Urban Setting The Role of Violence in Stimulant Use among Homeless and Unstably Housed Adult Women Living in a U.S. Urban Setting Elise D. Riley, PhD, MPH Martha Shumway, PhD Kelly R. Knight, PhD Jennifer Cohen, MPA

More information

Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence

Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence Importance of Viral Suppression to Reduce HIV Transmission: Recent Evidence Toye Brewer, MD Co-Director, Fogarty International Training Program University of Miami Miller School of Medicine Viral suppression

More information

Depression in People Living with HIV/AIDS: Outcomes, Risks and Opportunities for Intervention

Depression in People Living with HIV/AIDS: Outcomes, Risks and Opportunities for Intervention The Alfred Hospital Depression in People Living with HIV/AIDS: Outcomes, Risks and Opportunities for Intervention Final Report August 2005 Chief Investigator Associate Professor Anne Mijch Infectious Diseases

More information

Scottish Medicines Consortium

Scottish Medicines Consortium Scottish Medicines Consortium raltegravir, 400mg film-coated tablet (Isentress) No. (461/08) Merck, Sharp and Dohme Limited 04 April 2008 The Scottish Medicines Consortium has completed its assessment

More information

Contemporary Issues in Adolescent Care. Mental Health

Contemporary Issues in Adolescent Care. Mental Health Contemporary Issues in Adolescent Care Mental Health Outline of presentation Normal adolescent development Impact of HIV on adolescents Mental Disorders in adolescents Mental disorders in adolescents with

More information

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016

Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 Thresia Sebastian MD, MPH University of Colorado, Denver Global Health Disasters Course October 2016 1 Objectives of today s lecture Describe global goals in the fight against HIV Review the epidemiology

More information

UPDATE ON THE CLINICAL MANAGEMENT OF HIV IN BARBADOS

UPDATE ON THE CLINICAL MANAGEMENT OF HIV IN BARBADOS UPDATE ON THE CLINICAL MANAGEMENT OF HIV IN BARBADOS 82 nd UWI/ BAMP CME November 18th and 19th, 2017 Tiffany Jordan, MB BS Locum Clinical Medical Officer, Ladymeade Reference Unit OBJECTIVES 1. Epidemiology

More information

Antiretroviral Therapy During Pregnancy and Delivery: 2015 Update

Antiretroviral Therapy During Pregnancy and Delivery: 2015 Update Frontier AIDS Education and Training Center Antiretroviral Therapy During Pregnancy and Delivery: 2015 Update Brian R. Wood, MD Assistant Professor of Medicine, University of Washington Medical Director,

More information

HAND is Common and Important in Patients on ART

HAND is Common and Important in Patients on ART HAND is Common and Important in Patients on ART Igor Grant, MD, FRCP(C) Director HIV Neurobehavioral Research Program University of California, San Diego How is HAND diagnosed? How prevalent is it? Points

More information

Antiretroviral Therapy in HIV and Hepatitis Coinfection: What Do We Need to Consider?

Antiretroviral Therapy in HIV and Hepatitis Coinfection: What Do We Need to Consider? Antiretroviral Therapy in HIV and Hepatitis Coinfection: What Do We Need to Consider? Saturday 22nd March 2014, Mumbai, India Jürgen K. Rockstroh Department of Internal Medicine I University Hospital Bonn,

More information

Housing / Lack of Housing and HIV Prevention and Care

Housing / Lack of Housing and HIV Prevention and Care Housing / Lack of Housing and HIV Prevention and Care Evidence and Explanations Angela A. Aidala, PhD Columbia University Mailman School of Public Health Center for Homeless Prevention Studies WOMEN AS

More information

The Effect of Antidepressant Treatment on HIV and Depression Outcomes: Results from the SLAM DUNC Randomized Controlled Trial

The Effect of Antidepressant Treatment on HIV and Depression Outcomes: Results from the SLAM DUNC Randomized Controlled Trial The Effect of Antidepressant Treatment on HIV and Depression Outcomes: Results from the SLAM DUNC Randomized Controlled Trial Brian W. Pence, PhD MPH Associate Professor Department of Epidemiology, UNC-Chapel

More information

15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy

15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy 15 years Follow Up in a Cohort of Children diagnosed with HIV Cardiomyopathy Lecturer Ana Maria TudorMD PhD * Mariana Mărdărescu MD PhD * Professor Ioana Anca MD PhD * * National Institute for Infectious

More information

Michael Healy August 8, 2012 Irving CRC Research Proposal. 1. Study Purpose and Rationale

Michael Healy August 8, 2012 Irving CRC Research Proposal. 1. Study Purpose and Rationale Michael Healy August 8, 2012 Irving CRC Research Proposal Prevalence of diarrhea and gastrointestinal infection in severely malnourished Human Immunodeficiency Virus (HIV) infected children in Durban,

More information

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP

HIV: Pregnancy in Serodiscordant Couple. Dr Chow TS ID Clinic HPP HIV: Pregnancy in Serodiscordant Couple Dr Chow TS ID Clinic HPP Sexual Reproductive Health and Rights The recognition of the sexual and reproductive health and rights (SRHR) of all individuals and couples

More information

Primary Care for Persons Living with HIV

Primary Care for Persons Living with HIV Primary Care for Persons Living with HIV Brian Montague, DO MS MPH Assistant Professor of Medicine Division of Infectious Diseases Warren Alpert School of Medicine Brown University Outline What constitutes

More information

When to start: guidelines comparison

When to start: guidelines comparison The editorial staff When to start: guidelines comparison The optimal time to begin antiretroviral therapy remains a critical question for the HIV field, and consensus about the appropriate CD4+ cell count

More information

SA HIV Clinicians Society Adult ART guidelines

SA HIV Clinicians Society Adult ART guidelines SA HIV Clinicians Society Adult ART guidelines In draft format Graeme Meintjes (on behalf of the guidelines committee) Selected topics When to start ART First-line Second-line Third-line Patients with

More information

Outline. Epidemiology of Pediatric HIV 10/3/2012. I have no financial relationships with any commercial entity to disclose

Outline. Epidemiology of Pediatric HIV 10/3/2012. I have no financial relationships with any commercial entity to disclose Nutritional, Metabolic, and Gastrointestinal Complications in Pediatric HIV Infection Tracie L. Miller, MD Department of Pediatrics University of Miami, Miller School of Medicine I have no financial relationships

More information

Disparities in HIV Care. Slides prepared by Kirk Fergus, Intern National Quality Center

Disparities in HIV Care. Slides prepared by Kirk Fergus, Intern National Quality Center Disparities in HIV Care Slides prepared by Kirk Fergus, Intern National Quality Center At a glance At a glance MSM accounted for 61% of all new HIV infections in the U.S. in 2009, as well as nearly half

More information

Treat All : From Policy to Action - What will it take?

Treat All : From Policy to Action - What will it take? Strategy Finance Integration Cascade of services People centred Political Will Treat All : From Policy to Action - What will it take? Thursday, 9 June, 13.00 14.30 Conference Room 11, United Nations Questions

More information

Frailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting. Giovanni Guaraldi

Frailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting. Giovanni Guaraldi Frailty and age are independently associated with patterns of HIV antiretroviral use in a clinical setting Giovanni Guaraldi Potential conflicts of interest Research funding: Jansen, Gilead, MSD, BMS Consultancies:

More information

Test & Treat : Changing the face of insurance for persons living with HIV?

Test & Treat : Changing the face of insurance for persons living with HIV? Test & Treat : Changing the face of insurance for persons living with HIV? Kadene Gibbs FSA, MSc Dr Matthew Procter Agenda 1. Background 2. Understanding HIV and Factors affecting Prognosis 3. History

More information

OUTCOMES OF HIV-INFECTED THERAPY INCLUDING

OUTCOMES OF HIV-INFECTED THERAPY INCLUDING UNIVERSIDADE FEDERAL DA BAHIA FACULDADE DE MEDICINA DA BAHIA PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA E SAÚDE OUTCOMES OF HIV-INFECTED PATIENTS RECEIVING RESCUE THERAPY INCLUDING RALTEGRAVIR Patino-Escarcina

More information

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84

Goal of this chapter. 6.1 Introduction Good practices for linkage to care General care for people living with HIV 84 Clinical guidelines across THE CONTINuUM OF CARE: LINKING PEOPLE DIAGNOSEd WiTH hiv infection to hiv care and treatment 06 6.1 Introduction 84 6.2 Good practices for linkage to care 84 6.3 General care

More information

CADTH CANADIAN DRUG EXPERT COMMITTEE FINAL RECOMMENDATION

CADTH CANADIAN DRUG EXPERT COMMITTEE FINAL RECOMMENDATION CADTH CANADIAN DRUG EXPERT COMMITTEE FINAL RECOMMENDATION ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR ALAFENAMIDE (Genvoya Gilead Sciences Canada, Inc.) Indication: HIV-1 Infection Recommendation:

More information

Date of study period: April 12 May 7, 2010 and August September, 2010

Date of study period: April 12 May 7, 2010 and August September, 2010 Classification of antiretroviral therapy failure using immunologic and clinical versus virologic monitoring in HIV-infected children and adolescents in Cambodia Date of study period: April 12 May 7, 2010

More information

Many highly active antiretroviral therapy PROCEEDINGS

Many highly active antiretroviral therapy PROCEEDINGS MAXIMIZING THE EFFECTIVENESS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY: IS THERE A ROLE FOR QUADRUPLE REGIMENS? * François Raffi, MD, PhD ABSTRACT Although many highly active antiretroviral therapy (HAART)

More information

The Danish HIV Cohort Study, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark 4

The Danish HIV Cohort Study, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark 4 Antiviral Therapy 2009 14: 995 1000 (doi: 10.3851/IMP1412) Original article The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish

More information

D:A:D: Cumulative Exposure to DRV/r Increase MI Risk

D:A:D: Cumulative Exposure to DRV/r Increase MI Risk D:A:D: Cumulative Exposure to DRV/r Increase MI Risk 20.0-15.0-10.0-5.0-4.0-3.0-2.0-1.0- Unadjusted CVD rate ratios per 5 years additional exposure: ATV/r 1.25 [1.10-1.43] and DRV/r 1.93 [1.63-2.28] Adjusted*

More information

Professor Anna Maria Geretti

Professor Anna Maria Geretti THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Professor Anna Maria Geretti Institute of Infection & Global Health, University of Liverpool 1-4 April 2014, Arena and Convention Centre Liverpool THIRD JOINT

More information

Predictors of Adherence to Antiretroviral Medications in Children and Adolescents With HIV Infection

Predictors of Adherence to Antiretroviral Medications in Children and Adolescents With HIV Infection ARTICLE Predictors of Adherence to Antiretroviral Medications in Children and Adolescents With HIV Infection Paige L. Williams, PhD a, Deborah Storm, PhD, RN b, Grace Montepiedra, PhD a, Sharon Nichols,

More information

OPPORTUNISTIC INFECTIONS. Institute of Infectious Diseases, Pune India

OPPORTUNISTIC INFECTIONS. Institute of Infectious Diseases, Pune India OPPORTUNISTIC INFECTIONS Institute of Infectious Diseases, Pune India DISCLOSURES Nothing to declare Outline The problem Bacterial Fungal Protozoal Viral Decline in OI prevalence in HAART era: USA CROI

More information

Abiyie Zeleke. Department of Pediatrics and Child Health, Debre Markos University, Debre Markos, Ethiopia.

Abiyie Zeleke. Department of Pediatrics and Child Health, Debre Markos University, Debre Markos, Ethiopia. Vol. 8(11), pp. 125-132, November 2016 DOI: 10.5897/IJMMS2015.1164 Article Number: 9CC1DA261337 ISSN 2006-9723 Copyright 2016 Author(s) retain the copyright of this article http://www.academicjournals.org/ijmms

More information

Hepatitis B Case Studies

Hepatitis B Case Studies NORTHWEST AIDS EDUCATION AND TRAINING CENTER Hepatitis B Case Studies Nina Kim, MD MSc Associate Professor of Medicine University of Washington Harborview Madison Clinic and Hepatitis & Liver Clinic No

More information

Supplement Article. antiretroviral therapy; language development; language impairment; perinatal HIV; youth.

Supplement Article. antiretroviral therapy; language development; language impairment; perinatal HIV; youth. Supplement Article Longitudinal Evaluation of Language Impairment in Youth With Perinatally Acquired Human Immunodeficiency Virus (HIV) and Youth With Perinatal HIV Exposure Sean M. Redmond, 1 Tzy-Jyun

More information

Central Nervous System Penetration of ARVs: Does it Matter?

Central Nervous System Penetration of ARVs: Does it Matter? NORTHWEST AIDS EDUCATION AND TRAINING CENTER Central Nervous System Penetration of ARVs: Does it Matter? Christina M. Marra, MD Neurology and Medicine (Infectious Diseases) University of Washington 15

More information

Disclosures 12/7/17. UPDATES IN HIV NEUROLOGY Felicia Chow, MD, MAS University of California, San Francisco December 7, 2017

Disclosures 12/7/17. UPDATES IN HIV NEUROLOGY Felicia Chow, MD, MAS University of California, San Francisco December 7, 2017 UPDATES IN HIV NEUROLOGY Felicia Chow, MD, MAS University of California, San Francisco December 7, 2017 Disclosures I have nothing to disclose. Brain Compartment Zayyad et al. Curr HIV/AIDS Rep 2015 Clinical

More information

Adherence to ART in HIV-infected children in Kenya, South Africa, and Thailand

Adherence to ART in HIV-infected children in Kenya, South Africa, and Thailand Adherence to ART in HIV-infected children in Kenya, South Africa, and Thailand Rachel C. Vreeman, MD, MS Director of Research, IU Center for Global Health Associate Professor of Pediatrics Indiana University

More information

Module 6: ARVs in Children

Module 6: ARVs in Children Module 6: ARVs in Children Module Objectives To review the use of ARVs in children and their impact on disease progression To provide nurses with a general understanding of the differences in ARV use in

More information

Management of Antiretroviral Treatment (ART) and Long-Term Adherence to ART

Management of Antiretroviral Treatment (ART) and Long-Term Adherence to ART Thailand s Annual International Training Course (AITC) 2017 Management of Antiretroviral Treatment (ART) and Long-Term Adherence to ART I. Proposal Title: Management of Antiretroviral Treatment (ART) and

More information

The role of a Pharmacist in the analysis of adherence rates and associated factors in HIV-patients registered on Centralized Chronic Medicines

The role of a Pharmacist in the analysis of adherence rates and associated factors in HIV-patients registered on Centralized Chronic Medicines The role of a Pharmacist in the analysis of adherence rates and associated factors in HIV-patients registered on Centralized Chronic Medicines Dispensing and Distribution (CCMDD) programme in the public

More information

Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project,

Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project, Gender Disparities in Viral Suppression and Antiretroviral Therapy Use by Racial and Ethnic Group Medical Monitoring Project, 2009-2010 Linda Beer PhD, Christine L Mattson PhD, William Rodney Short MD,

More information

HIV Reproductive Health: Conception Options in the Era of PrEP

HIV Reproductive Health: Conception Options in the Era of PrEP HIV Reproductive Health: Conception Options in the Era of PrEP Meg Sullivan, MD Director, HIV Clinical Programs, Section of Infectious Diseases Boston Medical Center Boston University School of Medicine

More information

HIV, Co-infection & Aging: New Challenges for Gerontology

HIV, Co-infection & Aging: New Challenges for Gerontology HIV, Co-infection & Aging: New Challenges for Gerontology Colleen Price, Ron Rosenes & Jamie Hill Canadian Treatment Action Council Charles Furlotte McMaster University HIV/HCV Co-infection 30% of people

More information

PrEP for Women: HIV Prevention in Family Planning Settings

PrEP for Women: HIV Prevention in Family Planning Settings National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention PrEP for Women: HIV Prevention in Family Planning Settings Dawn K. Smith, MD, MS, MPH Division of HIV/AIDS Prevention dsmith1@cdc.gov

More information

Gender Differences in clinical and immunological outcomes in South African HIV-infected patients on HAART

Gender Differences in clinical and immunological outcomes in South African HIV-infected patients on HAART RESEARCH REPORT TITLE Gender Differences in clinical and immunological outcomes in South African HIV-infected patients on HAART Submitted for the degree: MSc (MED) EPIDEMIOLOGY AND BIOSTATISTICS School

More information

HBV in HIV Forgotten but not Gone

HBV in HIV Forgotten but not Gone Activity Code FA376 HBV in HIV Forgotten but not Gone Richard K. Sterling, MD, MSc VCU Hepatology Professor of Medicine Chief, Section of Hepatology Virginia Commonwealth University Learning Objectives

More information

CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA. Date

CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA. Date CUMULATIVE PERINATAL HIV EXPOSURE, AUSTRALIA 350 300 250 Number 200 150 100 50 0 1/01/1997 1/01/1998 1/01/1999 1/01/2000 31/12/2000 31/12/2001 31/12/2002 Date July 2004 Reported number of perinatally exposed

More information

Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania

Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania Dr. Fausta Franklin Mosha (MD, MSc, MSc, PHD) Ministry of Health and Social Welfare 22 nd October

More information

HIGH BURDEN OF METABOLIC COMORBIDITIES IN A CITYWIDE COHORT OF HIV OUTPATIENTS

HIGH BURDEN OF METABOLIC COMORBIDITIES IN A CITYWIDE COHORT OF HIV OUTPATIENTS HIGH BURDEN OF METABOLIC COMORBIDITIES IN A CITYWIDE COHORT OF HIV OUTPATIENTS Evolving Health Care Needs of People Aging with HIV in Washington, DC Matthew E. Levy 1, Alan E. Greenberg 1, Rachel Hart

More information

ID Week 2016: HIV Update

ID Week 2016: HIV Update Mountain West AIDS Education and Training Center ID Week 2016: HIV Update Robert Harrington, M.D. This presentation is intended for educational use only, and does not in any way constitute medical consultation

More information

Intermittent Antiretroviral Therapy (ART) Can Induce Reduction of Viral Rebounding During ART-Interruption

Intermittent Antiretroviral Therapy (ART) Can Induce Reduction of Viral Rebounding During ART-Interruption Lehigh Valley Health Network LVHN Scholarly Works Department of Medicine Intermittent Antiretroviral Therapy (ART) Can Induce Reduction of Viral Rebounding During ART-Interruption Joseph L. Yozviak DO,

More information

Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah

Obstetrics and HIV An Update. Jennifer Van Horn MD University of Utah Obstetrics and HIV An Update Jennifer Van Horn MD University of Utah Obstetrics and HIV Perinatal transmission Testing Antiretroviral therapy Antepartum management Intrapartum management Postpartum management

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: Enfuvirtide (Fuzeon) Reference Number: CP.PHAR.41 Effective Date: 10.01.18 Last Review Date: 07.13.18 Line of Business: Oregon Health Plan Revision Log See Important Reminder at the end

More information

A SIMULATION MODEL OF HIV TREATMENT UNDER DRUG SCARCITY CONSTRAINTS. Robert T. Koppenhaver R. Scott Braithwaite Mark Roberts Andrew Schaefer

A SIMULATION MODEL OF HIV TREATMENT UNDER DRUG SCARCITY CONSTRAINTS. Robert T. Koppenhaver R. Scott Braithwaite Mark Roberts Andrew Schaefer Proceedings of the 2009 Winter Simulation Conference M. D. Rossetti, R. R. Hill, B. Johansson, A. Dunkin and R. G. Ingalls, eds. A SIMULATION MODEL OF HIV TREATMENT UNDER DRUG SCARCITY CONSTRAINTS ABSTRACT

More information

Virological suppression and PIs. Diego Ripamonti Malattie Infettive - Bergamo

Virological suppression and PIs. Diego Ripamonti Malattie Infettive - Bergamo Virological suppression and PIs Diego Ripamonti Malattie Infettive - Bergamo Ritonavir-boosted PIs Boosted PIs: 3 drugs in one The intrinsic antiretroviral activity Viral suppression and high baseline

More information

CD4 nadir and antiretroviral exposure predict premature polypathology onset

CD4 nadir and antiretroviral exposure predict premature polypathology onset CD4 nadir and antiretroviral exposure predict premature polypathology onset Guaraldi Giovanni Metabolic Clinic Infectious and Tropical Disease Unit University of Modena and Reggio Emilia, Modena, Italy

More information

Adherence Redux. Gordon Dickinson, MD Chief, ID, U Miami School of Medicine, and Co-Director, Special Immunology, Miami VA Med Center

Adherence Redux. Gordon Dickinson, MD Chief, ID, U Miami School of Medicine, and Co-Director, Special Immunology, Miami VA Med Center Adherence Redux Gordon Dickinson, MD Chief, ID, U Miami School of Medicine, and Co-Director, Special Immunology, Miami VA Med Center To Be Human Is To Err People, on the whole, are not particularly adherent

More information

International Symposium on. Barcelona, May 5 th and 6 th 2011

International Symposium on. Barcelona, May 5 th and 6 th 2011 th International Symposium on Barcelona, May 5 th and 6 th 2011 4rd Symposium on Psychiatry and HIV --- Barcelona, May 6th 2010 Neurocognitive Testing in HIV Infection: How to Implement this Assessment

More information

The impact of antiretroviral drugs on renal function

The impact of antiretroviral drugs on renal function The impact of antiretroviral drugs on renal function Professor Bruce Hendry Renal Medicine King s College London King s College Hospital NHS Foundation Trust 1 DISCLOSURES: BRUCE HENDRY I have received

More information

Relationship between Demographic Factors, Stage of Disease and Adherence among HIV/AIDS Patients Receiving Highly Active Antiretroviral Therapy

Relationship between Demographic Factors, Stage of Disease and Adherence among HIV/AIDS Patients Receiving Highly Active Antiretroviral Therapy Relationship between Demographic Factors, Stage of Disease and Adherence among HIV/AIDS Patients Receiving Highly Active Antiretroviral Therapy Chongthawonsatid S, Ruansawang P, Prasithsirikul W, et al

More information

HIV-HBV coinfection: Issues with treatment in 2018

HIV-HBV coinfection: Issues with treatment in 2018 HIV-HBV coinfection: Issues with treatment in 2018 Pr Karine Lacombe, INSERM UMR-S1136, IPLESP Infectious Diseases Dpt, St Antoine, AP-HP Sorbonne Université, Paris, France Global epidemiology Same routes

More information

Express Scripts, Inc. monograph dated 5/25/2011; selected revision 6/1/2011

Express Scripts, Inc. monograph dated 5/25/2011; selected revision 6/1/2011 BENEFIT DESCRIPTION AND LIMITATIONS OF COVERAGE ITEM: PRODUCT LINES: COVERED UNDER: DESCRIPTION: CPT/HCPCS Code: Company Supplying: Setting: Coverage Criteria: Approval Period: Victrelis (boceprevir capsules)

More information

Il percorso sulla diagnosi del carcinoma anale. Cristina Mussini

Il percorso sulla diagnosi del carcinoma anale. Cristina Mussini Il percorso sulla diagsi del carcima anale Cristina Mussini Standardized Incidence Ratio (SIR) of AIDS-defining cancers in 99.309 pts with HIV/AIDS from French registry-linkage study in different cart

More information

Transitional Care for HIV and AIDS from Adolescence to Adulthood

Transitional Care for HIV and AIDS from Adolescence to Adulthood Transitional Care for HIV and AIDS from Adolescence to Adulthood October 2011 Featured Speaker Conflict of Interest Statement Jeffrey M. Birnbaum, MD, MPH Associate Professor of Pediatrics and Public Health,

More information

WHO recommendations for HIVDR surveillance and their application in Latin America and the Caribbean

WHO recommendations for HIVDR surveillance and their application in Latin America and the Caribbean WHO recommendations for HIVDR surveillance and their application in Latin America and the Caribbean Giovanni Ravasi Pan-American Health Organization, Brazil ravasigi@paho.org Regional Consultation on HIV

More information

HIV treatment interruptions are associated with heightened biomarkers of inflammation, coagulopathy and T-cell activation despite viral suppression

HIV treatment interruptions are associated with heightened biomarkers of inflammation, coagulopathy and T-cell activation despite viral suppression HIV treatment interruptions are associated with heightened biomarkers of inflammation, coagulopathy and T-cell activation despite viral suppression Nicholas Musinguzi on behalf of Jose Castillo-Mancila,

More information

Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention

Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention Pre exposure Prophylaxis (PrEP): Stepping Up HIV Prevention Dawn K. Smith, MD, MS, MPH Centers for Disease Control and Prevention The findings and conclusions in this presentation have not been formally

More information

All HIV+ Women on Antiretroviral Therapy Should Breastfeed in Both Low and High Resource Settings VOTE NO!!

All HIV+ Women on Antiretroviral Therapy Should Breastfeed in Both Low and High Resource Settings VOTE NO!! All HIV+ Women on Antiretroviral Therapy Should Breastfeed in Both Low and High Resource Settings VOTE NO!! Lynne Mofenson MD Elizabeth Glaser Pediatric AIDS Foundation My Esteemed Opponent Will Likely

More information

ASSESSING ADHERENCE TO COMBINATION ART IN AN URBAN PRIVATE HOSPITAL DR. EVELYN MBUGUA AGA KHAN UNIVERSITY HOSPITAL

ASSESSING ADHERENCE TO COMBINATION ART IN AN URBAN PRIVATE HOSPITAL DR. EVELYN MBUGUA AGA KHAN UNIVERSITY HOSPITAL ASSESSING ADHERENCE TO COMBINATION ART IN AN URBAN PRIVATE HOSPITAL DR. EVELYN MBUGUA AGA KHAN UNIVERSITY HOSPITAL ACKNOWLEDGMENT Supervisors: Prof. Gerald Yonga, Chairman,Dept of Medicine Dr. Reena Shah,

More information

HIV and FDC aspects of two guidelines. Filip Josephson

HIV and FDC aspects of two guidelines. Filip Josephson HIV and FDC aspects of two guidelines Filip Josephson Status Ongoing process Updated draft guideline for HIV drug development available for public consultation on EMA website since 2013 Presently under

More information

IMPACT OF PILL BURDEN AND SOCIO-ECONOMIC STATUS OF PATIENTS ON ADHERENCE TO PHARMACOLOGIC THERAPY IN ELDERLY

IMPACT OF PILL BURDEN AND SOCIO-ECONOMIC STATUS OF PATIENTS ON ADHERENCE TO PHARMACOLOGIC THERAPY IN ELDERLY The West London Medical Journal 2014 Vol 6 No 1 pp 23-28 IMPACT OF PILL BURDEN AND SOCIO-ECONOMIC STATUS OF PATIENTS ON ADHERENCE TO PHARMACOLOGIC THERAPY IN ELDERLY Anil Kumar Jeetendra Kumar Balakrisnan

More information

It takes more than just a single target

It takes more than just a single target It takes more than just a single target As the challenges you face evolve... HIV mutates No HIV-1 mutation can be considered to be neutral 1 Growing evidence indicates all HIV subtypes may be prone to

More information